Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
01/2003
01/30/2003US20030022284 Polypeptide for use in the diagnosis and treatment of kidney defects
01/30/2003US20030022283 Neuropeptide Y receptor Y5 and nucleic acid sequences
01/30/2003US20030022211 Nucleotide sequences coding polypeptide for use in diagnosis and prevention of psychological and nervous system disorders
01/30/2003US20030022179 Methods and reagents for molecular cloning
01/30/2003US20030021796 Method of enhancing T cell immunity by selection of antigen specific T cells
01/30/2003US20030021788 Novel human STRA6-like protein and nucleic acids encoding the same
01/30/2003CA2453949A1 Populations of dairy cows producing milk with desirable characteristics and methods of making and using same
01/30/2003CA2453249A1 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer
01/30/2003CA2452795A1 Aquaculture of marine worms
01/29/2003EP1279744A2 Identification and use of molecules implicated in pain
01/29/2003EP1279332A2 Transgenic non-human mammal
01/29/2003EP1279038A2 Method of identifying agents that alter the activity of the promoter sequence for crf receptor 2-alpha
01/29/2003EP1278853A2 Listeria monocytogenes genome, polypeptides and uses
01/29/2003EP1278849A2 Thrombopoietin receptor modulating peptide
01/29/2003EP1278843A2 Rna metabolism proteins
01/29/2003EP1278839A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
01/29/2003EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
01/29/2003EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
01/29/2003EP1278827A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
01/29/2003EP1278776A2 Isolated human transporter proteins, nucleic acids and uses thereof
01/29/2003EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
01/29/2003EP1278774A2 Human g-protein coupled receptors
01/28/2003US6512161 Genomic DNA sequences that encode apolipoprotein (A) and apolipoprotein B polypeptides
01/28/2003US6511830 Envelope protein gp 160
01/28/2003US6511824 Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use
01/28/2003US6510811 Method for localizing allantoic fluid of avian eggs
01/27/2003CA2391642A1 Identification and use of molecules implicated in pain
01/27/2003CA2391219A1 Identification and use of molecules implicated in pain
01/27/2003CA2391216A1 Identification and use of molecules implicated in pain
01/27/2003CA2391112A1 Identification and use of molecules implicated in pain
01/23/2003WO2003006996A2 Natural ligand of gpcr chemr23 and uses thereof
01/23/2003WO2003006477A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING
01/23/2003WO2003005812A2 Modulation of metabolism of steroids and xenobiotics
01/23/2003WO2003005811A1 Il-18 transgenic animal
01/23/2003WO2002066509A3 Treatment involving dkk-1 or antagonists thereof
01/23/2003WO2002024906A9 Induction of exon skipping in eukaryotic cells
01/23/2003WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
01/23/2003WO2001090333A3 Recombinant bacterial phytases and uses thereof
01/23/2003US20030018987 Animal model for use in the diagnosis and treatment of eating, apoptosis and infectious disorders
01/23/2003US20030018984 IGF-I expression system and methods of use
01/23/2003US20030018165 Uses of suppressive macrophage activation factors
01/23/2003US20030017600 Double selection vector
01/23/2003US20030017593 Vector for use as tool in gene therapy
01/23/2003US20030017583 Recovery and disposal of animal feces; obtain feces, insert into container, tranfer to facility, dispose of waste
01/23/2003US20030017577 Aparatus for monitoring the activity of inectious nematodes
01/23/2003US20030017548 Proteins for use in treatment of gastrointestinal disorders
01/23/2003US20030017534 Production of humanized antibodies in transgenic animals
01/23/2003US20030017527 Human vanilloid receptor-like proteins
01/23/2003US20030017510 Apparatus for use in cell transplantation
01/23/2003US20030017470 Novel PRKAG3 alleles and use of the same as genetic markers for reproductive and meat quality traits
01/23/2003US20030017231 Feeding the aquatic species during larval and/or post-larval stage with prey organisms having 12% of 4,7,10,13,16,19-docosahexaenoic acid (dha) in lipid content
01/23/2003US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2
01/23/2003US20030017160 Human checkpoint kinase, hCDS1, compositions and methods
01/23/2003US20030017150 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
01/23/2003CA2453183A1 In vivo production of small interfering rnas that mediate gene silencing
01/22/2003EP1277836A1 Modulation of the IAPs and NAIP for the treatment of proliferative diseases
01/22/2003EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
01/22/2003EP1276879A1 MUIR-TORRE-LIKE SYNDROME IN Fhit DEFICIENT MICE
01/22/2003EP1276851A2 Tolerance-inducing thymus-bone marrow composite tissue construct and organ
01/22/2003EP1276371A2 Transgenic animal
01/22/2003CN1392772A Animal showing schizophrenia-like abnormality in coagnitive behaviors and method of construction same
01/22/2003CN1391798A Cultivating method for black ear high yield wool producing rabbit
01/22/2003CN1099232C Ocyodinic for giant salamander and its using method
01/21/2003US6509515 Transgenic mice expressing mutant human APP and forming congo red staining plaques
01/21/2003US6509514 Chimeric animal model susceptible to human hepatitis C virus infection
01/17/2003CA2407295A1 Transgenic non-human mammal
01/16/2003WO2003004684A2 NUCLEIC ACIDS ENCODING A RECOMBINANT 250 kDa ANTIGEN FROM SPOROZOITES/MEROZOITES OF EIMERIA MAXIMA AND THEIR USES
01/16/2003WO2003004683A2 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses
01/16/2003WO2003004659A2 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms
01/16/2003WO2003004644A1 Delivery of dsrna to arthropods
01/16/2003WO2003004626A1 A bioprocess for the generation of cells derived from spheroid-forming cells
01/16/2003WO2003003824A1 Potential-dependent ca2+ channel a1b knockout non-human animal
01/16/2003WO2002040540A3 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
01/16/2003WO2002022806A3 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
01/16/2003WO2001092490A3 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof
01/16/2003WO2001070174A8 Vegf-modulated genes and methods employing them
01/16/2003WO2001053340A9 Transgenic mouse model of human neurodegenerative disease
01/16/2003US20030014770 Alpha (1,3) galactosyl transferase negative swine
01/16/2003US20030013942 Animal health care, well-being and nutrition
01/16/2003US20030013650 VR-OAC, an osomotically activated channel protein, nucleic acids encoding it, and uses thereof
01/16/2003US20030013636 Prevent biosynthesis of galactoside
01/16/2003US20030013191 Transgenic cells for use in human therapeutics and diagnostics
01/16/2003US20030013181 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
01/16/2003US20030013093 Diagnosis of diabetes and insulin resistance in humans; obtain adipose cells, extract nucleotide sequences, determine gene expression patterns, evaluate for diabetes and insulin resistance
01/16/2003US20030013087 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
01/16/2003US20030012769 Wherein a part or all of a regulatory element of the U3 region of the 5' LTR is replaced by another regulatory element, operable in a mammalian cell, which is not endogenous to said lentivirus.
01/16/2003US20030010293 Apparatus and method for separation of nematodes from suspension
01/16/2003CA2488550A1 A bioprocess for producing uniform embryoid bodies from embryonic stem cells in a high density bioreactor
01/16/2003CA2467006A1 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses
01/16/2003CA2455490A1 Delivery of dsrna to arthropods
01/16/2003CA2451492A1 Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms
01/15/2003EP1274857A1 Inhibitor of differentiation knockout mammals and methods of use thereof
01/15/2003EP1274464A2 Compositions and methods for regulated protein expression in gut
01/14/2003US6506597 Comprising a mixture of cooked egg, liqiud and carbohydrate; for mass production of insects used in biological pest control; growth medium free of meat paste and insect components; cost efficiency
01/14/2003US6506587 Nucleotide sequences coding enzymatic polypeptide; for use as an antitumor a gents
01/14/2003US6506570 Method of sorting birds in ovo
01/14/2003US6506559 Molecular hybridization of complementary strands
01/09/2003WO2003003013A1 Non-nuclear effects of thyroid hormone
01/09/2003WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease
01/09/2003WO2003002746A2 Perv screening method and use thereof